Last reviewed · How we verify

NCT04890483

tDCS in Post-Acute COVID-19 Patients With SARDs

Recruiting now NA Last updated 5 December 2024
What this trial tests

NA trial testing Transcranial direct current stimulation in Rheumatic Diseases in 20 participants. Currently enrolling.

Timeline
17 May 2021
Primary endpoint
6 May 2024
4 December 2024

Quick facts

Lead sponsorUniversity of Sao Paulo
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date17 May 2021
Primary completion6 May 2024
Estimated completion4 December 2024
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of Sao Paulo

Who can join

Adults 18 to 80, any sex, with Rheumatic Diseases or Autoimmune Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Some patients develop "Post-acute COVID-19 syndrome," in which they experience persistent symptoms after recovering from the acute phase of COVID-19 infection. This syndrome may be more significant in patients with systemic autoimmune rheumatic diseases (SARDs) who have been suffering from several symptoms associated to SARDs, such as myalgia, fatigue, and general pains. The transcranial direct current stimulation (tDCS) technique has been frequent, for example, to relieve fatigue and general pains in general population. However, to date, there are no studies evaluating this technique in ARD patients with post-acute COVID-19; therefore, the main objective of the opened study is to evaluate the safety and efficacy of the application of acute tDCS in ARD patients with post-acute COVID-19.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Transcranial direct current electrical stimulation in combination with aerobic exercise is effective in reducing fatigue and pain in post-COVID-19 systemic autoimmune rheumatic patients
    Missé RG, Santos AMd, Borges IBP, Simões MSM, et al · · 2021 · DOI 10.21203/rs.3.rs-1008362/v1

Verify or expand the search:

Other trials of Transcranial direct current stimulation

Trials testing the same drug.

Other recruiting trials for Rheumatic Diseases

Currently open trials in the same condition.

Other University of Sao Paulo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04890483.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing